FDA gets more Money
Recommendation

2/3 September 2026
Copenhagen, Denmark
When “Human Error” isn’t enough: Successful Failure Investigation
The US Food & Drug Administration's (FDA) budget for the fiscal year (FY) 2018 will be higher than the one for the FY 2017. This was approved by the U.S. Senate Subcommittee on Appropriations. The authority's budget is part of the Agriculture Appropriations Bill and includes 2.8 billion US$ discretionary funding for the FDA. This is 1 million over the FY2017 budget. Including user fee revenues, total FDA funding will be 5.2 billion US$ (which is 491 million US$ above FY2017). The bill also provides 60 million US$ as authorized in the 21st Century Cures Act.
Related GMP News
20.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan
19.08.2026FDA: Simplified Registration for U.S. Sites and Greater Complexity for Non-U.S. Sites
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?


